Skip to main content
Top
Published in: Clinical Rheumatology 4/2010

01-04-2010 | Original Article

Evidence for generalized hyperalgesia in chronic fatigue syndrome: a case control study

Authors: Mira Meeus, Jo Nijs, Sven Huybrechts, Steven Truijen

Published in: Clinical Rheumatology | Issue 4/2010

Login to get access

Abstract

Several studies provided evidence for generalized hyperalgesia in fibromyalgia or whiplash-associated disorders. In chronic fatigue syndrome, however, pain is a frequently reported complaint, but up to now, evidence for generalized hyperalgesia is lacking. The aim of this study is to examine whether the pressure pain thresholds (PPTs) at both symptomatic and asymptomatic sites differ in chronic fatigue syndrome (CFS) patients with chronic pain, compared to healthy controls. Therefore, 30 CFS patients with chronic pain and 30 age- and gender-matched healthy controls indicated on a Margolis Pain Diagram where they felt pain lasting longer than 24 h in the past 4 weeks. After completing a test battery of questionnaires evaluating pain cognitions, functional status and symptomatology, a blinded researcher assessed PPTs bilaterally at seven non-specific sites on both trunk and extremities. PPTs were compared for the two complete groups. In addition, PPTs of patients and controls who did not report pain in a respective zone were compared. PPTs of the patients were significantly lower (p < 0.001) compared to those of the control group, also when pain-free samples per zone were compared (p < 0.001). The mean PPT was 3.30 kg/cm2 in all CFS patients and 8.09 kg/cm2 in the controls. No confounding factors responsible for the observed differences, as, e.g., catastrophizing and depression, could be revealed. These findings provide evidence for the existence of hyperalgesia even in asymptomatic areas (generalized secondary hyperalgesia). The generalized hyperalgesia may represent the involvement of a sensitized central nervous system.
Literature
2.
go back to reference Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, McCready W, Huang CF, Plioplys S (1999) A community-based study of chronic fatigue syndrome. Arch Intern Med 159:2129–2137.CrossRefPubMed Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, McCready W, Huang CF, Plioplys S (1999) A community-based study of chronic fatigue syndrome. Arch Intern Med 159:2129–2137.CrossRefPubMed
3.
go back to reference Bradley LA, McKendree-Smith NL, Alarcon GS (2000) Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome. Curr Rev Pain 4:148–157.PubMed Bradley LA, McKendree-Smith NL, Alarcon GS (2000) Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome. Curr Rev Pain 4:148–157.PubMed
4.
go back to reference Staud R, Smitherman ML (2002) Peripheral and central sensitization in fibromyalgia: pathogenetic role. Curr Pain Headache Rep 6:259–266.CrossRefPubMed Staud R, Smitherman ML (2002) Peripheral and central sensitization in fibromyalgia: pathogenetic role. Curr Pain Headache Rep 6:259–266.CrossRefPubMed
5.
go back to reference Banic B, Petersen-Felix S, Andersen OK, Radanov BP, Villiger PM, Arendt-Nielsen L, Curatolo M (2004) Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain 107:7–15.CrossRefPubMed Banic B, Petersen-Felix S, Andersen OK, Radanov BP, Villiger PM, Arendt-Nielsen L, Curatolo M (2004) Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain 107:7–15.CrossRefPubMed
6.
go back to reference Sterling M, Jull G, Vicenzino B, Kenardy J (2004) Characterization of acute whiplash-associated disorders. Spine 29:182–188.CrossRefPubMed Sterling M, Jull G, Vicenzino B, Kenardy J (2004) Characterization of acute whiplash-associated disorders. Spine 29:182–188.CrossRefPubMed
7.
go back to reference Coderre TJ, Katz J, Vaccarino AL, Melzack R (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52:259–85.CrossRefPubMed Coderre TJ, Katz J, Vaccarino AL, Melzack R (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52:259–85.CrossRefPubMed
8.
go back to reference Meeus M, Nijs J (2007) Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol 26:465–73.CrossRefPubMed Meeus M, Nijs J (2007) Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol 26:465–73.CrossRefPubMed
9.
go back to reference Koelbaek Johansen M, Graven-Nielsen T, Schou Olesen A, Arendt-Nielsen L (1999) Generalised muscular hyperalgesia in chronic whiplash syndrome. Pain 83:229–34.CrossRefPubMed Koelbaek Johansen M, Graven-Nielsen T, Schou Olesen A, Arendt-Nielsen L (1999) Generalised muscular hyperalgesia in chronic whiplash syndrome. Pain 83:229–34.CrossRefPubMed
10.
go back to reference Giesbrecht RJ, Battie MC (2005) A comparison of pressure pain detection thresholds in people with chronic low back pain and volunteers without pain. Phys Ther 85:1085–92.PubMed Giesbrecht RJ, Battie MC (2005) A comparison of pressure pain detection thresholds in people with chronic low back pain and volunteers without pain. Phys Ther 85:1085–92.PubMed
11.
go back to reference Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121:953–9.PubMed Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121:953–9.PubMed
12.
go back to reference Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–72.CrossRefPubMed Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–72.CrossRefPubMed
13.
go back to reference Margolis RB, Tait RC, Krause SJ (1986) A rating system for use with patient pain drawings. Pain 24:57–65.CrossRefPubMed Margolis RB, Tait RC, Krause SJ (1986) A rating system for use with patient pain drawings. Pain 24:57–65.CrossRefPubMed
14.
go back to reference Whiteside A, Hansen S, Chaudhuri A (2004) Exercise lowers pain threshold in chronic fatigue syndrome. Pain 109:497–9.CrossRefPubMed Whiteside A, Hansen S, Chaudhuri A (2004) Exercise lowers pain threshold in chronic fatigue syndrome. Pain 109:497–9.CrossRefPubMed
15.
go back to reference Farasyn A, Meeusen R (2005) The influence of non-specific low back pain on pressure pain thresholds and disability. Eur J Pain 9:375–81.CrossRefPubMed Farasyn A, Meeusen R (2005) The influence of non-specific low back pain on pressure pain thresholds and disability. Eur J Pain 9:375–81.CrossRefPubMed
16.
go back to reference Farasyn A, Meeusen R (2003) Pressure pain thresholds in healthy subjects: influence of physicaal activity, history of lower back pain factors and the use of endermology as a placebo-like treatment. J Bodywork Mov Ther 7:53–61.CrossRef Farasyn A, Meeusen R (2003) Pressure pain thresholds in healthy subjects: influence of physicaal activity, history of lower back pain factors and the use of endermology as a placebo-like treatment. J Bodywork Mov Ther 7:53–61.CrossRef
17.
go back to reference Kosek E, Ekholm J, Hansson P (1999) Pressure pain thresholds in different tissues in one body region. The influence of skin sensitivity in pressure algometry. Scand J Rehabil Med 31:89–93CrossRefPubMed Kosek E, Ekholm J, Hansson P (1999) Pressure pain thresholds in different tissues in one body region. The influence of skin sensitivity in pressure algometry. Scand J Rehabil Med 31:89–93CrossRefPubMed
18.
go back to reference Bishop SR, Edgley K, Fisher R, Sullivan MJL (1993) Screening for depression in chronic low back pain with the Beck Depression Inventory. Can J Rehab 7:143–148. Bishop SR, Edgley K, Fisher R, Sullivan MJL (1993) Screening for depression in chronic low back pain with the Beck Depression Inventory. Can J Rehab 7:143–148.
19.
go back to reference Van Damme S, Crombez G, Bijttebier P, Goubert L, Van Houdenhove B (2002) A confirmatory factor analysis of the Pain Catastrophizing Scale: invariant factor structure across clinical and non-clinical populations. Pain 96:319–24.CrossRefPubMed Van Damme S, Crombez G, Bijttebier P, Goubert L, Van Houdenhove B (2002) A confirmatory factor analysis of the Pain Catastrophizing Scale: invariant factor structure across clinical and non-clinical populations. Pain 96:319–24.CrossRefPubMed
20.
go back to reference Roelofs J, Peters ML, McCracken L, Vlaeyen JW (2003) The pain vigilance and awareness questionnaire (PVAQ): further psychometric evaluation in fibromyalgia and other chronic pain syndromes. Pain 101:299–306.CrossRefPubMed Roelofs J, Peters ML, McCracken L, Vlaeyen JW (2003) The pain vigilance and awareness questionnaire (PVAQ): further psychometric evaluation in fibromyalgia and other chronic pain syndromes. Pain 101:299–306.CrossRefPubMed
21.
go back to reference Ware JE, Jr., Snow KK, Kosinki M, Gandek B (1993) SF-36 Health Survey manual and interpretation guide, The Health Institute, Boston Ware JE, Jr., Snow KK, Kosinki M, Gandek B (1993) SF-36 Health Survey manual and interpretation guide, The Health Institute, Boston
22.
go back to reference McHorney CA, Ware JE Jr., Raczek AE (1993) The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247–63.CrossRefPubMed McHorney CA, Ware JE Jr., Raczek AE (1993) The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247–63.CrossRefPubMed
23.
go back to reference Nijs J, Thielemans A (2008) Kinesiophobia and symptomatology in chronic fatigue syndrome: a psychometric study of two questionnaires. Psychology and Psychotherapy: Theory, Research and Practice 81:273–283. Nijs J, Thielemans A (2008) Kinesiophobia and symptomatology in chronic fatigue syndrome: a psychometric study of two questionnaires. Psychology and Psychotherapy: Theory, Research and Practice 81:273–283.
24.
go back to reference Meeus M, Nijs J, Van de Wauwer N, Toeback L, Trujen S (2008) Diffuse noxious inhibitory control is delayed in chronic fatigue syndrome: An experimental study. Pain 139:439–448.CrossRefPubMed Meeus M, Nijs J, Van de Wauwer N, Toeback L, Trujen S (2008) Diffuse noxious inhibitory control is delayed in chronic fatigue syndrome: An experimental study. Pain 139:439–448.CrossRefPubMed
25.
go back to reference Zusman M (2002) Forebrain-mediated sensitization of central pain pathways: ‘non-specific’ pain and a new image for MT. Man Ther 7:80–8.CrossRefPubMed Zusman M (2002) Forebrain-mediated sensitization of central pain pathways: ‘non-specific’ pain and a new image for MT. Man Ther 7:80–8.CrossRefPubMed
Metadata
Title
Evidence for generalized hyperalgesia in chronic fatigue syndrome: a case control study
Authors
Mira Meeus
Jo Nijs
Sven Huybrechts
Steven Truijen
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 4/2010
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1339-0

Other articles of this Issue 4/2010

Clinical Rheumatology 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine